0001225208-12-004844.txt : 20120221
0001225208-12-004844.hdr.sgml : 20120220
20120221173110
ACCESSION NUMBER: 0001225208-12-004844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120216
FILED AS OF DATE: 20120221
DATE AS OF CHANGE: 20120221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dawkins Keith D
CENTRAL INDEX KEY: 0001492253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 12627871
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC
STREET 2: ONE BOSTON SCIENTIFIC PLACE
CITY: NATICK
STATE: MA
ZIP: 01760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
BUSINESS PHONE: 508-650-8000
MAIL ADDRESS:
STREET 1: ONE BOSTON SCIENTIFIC PL
CITY: NATICK
STATE: MA
ZIP: 01760-1537
4
1
doc4.xml
X0304
4
2012-02-16
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001492253
Dawkins Keith D
ONE BOSTON SCIENTIFIC PLACE
NATICK
MA
01760-1537
1
Sr. VP, Global Chief Med. Off.
Common Stock
2012-02-16
4
M
0
3373.0000
0.0000
A
58191.0000
D
Common Stock
2012-02-16
4
F
0
1211.0000
5.9700
D
56980.0000
D
Deferred Stock Units
2012-02-16
4
M
0
3373.0000
0.0000
D
Common Stock
3373.0000
52566.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
The award vests in five equal installments beginning on February 16, 2011, the first anniversary of the date of grant.
dawkins.txt
/s/ Conor Kilroy, Attorney-in-Fact
2012-02-21
EX-24
2
dawkins.txt
POWER OF ATTORNEY
Know all by these present that the undersigned hereby constitutes and appoints
each of Timothy A. Pratt, Vance R. Brown, Theresa R. Boni, Todd D. Hammond,
Conor Kilroy and Marissa S. Frerk signing singly, the undersigned's true and
lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or director of Boston Scientific Corporation (the
"Company"), Forms 3, 4 and 5, and amendments thereto, in accordance with Section
16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
and file such form with the United States Securities and Exchange Commission and
any stock exchange or similar authority;
(3) execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive officer and/or director of the Company, Forms 144 in accordance
with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules
and regulations thereunder; and
(4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the
Securities Act of 1933, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 10th day of February, 2012.
/s/ Keith D. Dawkins, M.D.
Keith D. Dawkins, M.D.